[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UA120923C2 - Молекула нуклеїнової кислоти, яка кодує капсидний протеїн aav5 - Google Patents

Молекула нуклеїнової кислоти, яка кодує капсидний протеїн aav5

Info

Publication number
UA120923C2
UA120923C2 UAA201609350A UAA201609350A UA120923C2 UA 120923 C2 UA120923 C2 UA 120923C2 UA A201609350 A UAA201609350 A UA A201609350A UA A201609350 A UAA201609350 A UA A201609350A UA 120923 C2 UA120923 C2 UA 120923C2
Authority
UA
Ukraine
Prior art keywords
further improved
insect cells
aav vectors
vectors produced
improved aav
Prior art date
Application number
UAA201609350A
Other languages
English (en)
Inventor
Йасек Любельскі
Йасек Любельски
Себастіан Менно Босма
Себастиан Менно Босма
Харальд Петер Альберт Петрі
Харальд Петер Альберт Петри
Вільхельмус Теодорус Йоханнес Марія Крістіан Херменс
Вильхельмус Теодорус Йоханнес Мария Кристиан Херменс
Original Assignee
Юнікьюре Айпі Б.В.
ЮНИКЬЮРЕ АйПи Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнікьюре Айпі Б.В., ЮНИКЬЮРЕ АйПи Б.В. filed Critical Юнікьюре Айпі Б.В.
Publication of UA120923C2 publication Critical patent/UA120923C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Винахід стосується молекули нуклеїнової кислоти, конструкта, що містить молекулу нуклеїнової кислоти, клітини комахи, яка містить конструкт, AAV5 віріону та способу отримання AAV5 в клітині комахи.
UAA201609350A 2014-03-10 2015-03-10 Молекула нуклеїнової кислоти, яка кодує капсидний протеїн aav5 UA120923C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14158610 2014-03-10
PCT/NL2015/050149 WO2015137802A1 (en) 2014-03-10 2015-03-10 Further improved aav vectors produced in insect cells

Publications (1)

Publication Number Publication Date
UA120923C2 true UA120923C2 (uk) 2020-03-10

Family

ID=50238253

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201609350A UA120923C2 (uk) 2014-03-10 2015-03-10 Молекула нуклеїнової кислоти, яка кодує капсидний протеїн aav5

Country Status (17)

Country Link
US (2) US10837027B2 (uk)
EP (2) EP4450630A2 (uk)
JP (2) JP6683397B2 (uk)
KR (1) KR102572449B1 (uk)
CN (1) CN106459984B (uk)
AU (1) AU2015230094B2 (uk)
BR (1) BR112016020783A2 (uk)
CA (1) CA2942289C (uk)
DK (1) DK3117005T3 (uk)
EA (1) EA201691809A1 (uk)
FI (1) FI3117005T3 (uk)
IL (1) IL247729B2 (uk)
MX (1) MX2016011585A (uk)
PT (1) PT3117005T (uk)
UA (1) UA120923C2 (uk)
WO (1) WO2015137802A1 (uk)
ZA (1) ZA201606552B (uk)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10577627B2 (en) 2014-06-09 2020-03-03 Voyager Therapeutics, Inc. Chimeric capsids
SG11201703148TA (en) 2014-11-05 2017-05-30 Voyager Therapeutics Inc Aadc polynucleotides for the treatment of parkinson's disease
EP3218484A4 (en) 2014-11-14 2018-05-30 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (als)
CN112375760A (zh) 2014-11-14 2021-02-19 沃雅戈治疗公司 调节性多核苷酸
EP3230441A4 (en) 2014-12-12 2018-10-03 Voyager Therapeutics, Inc. Compositions and methods for the production of scaav
WO2017181162A1 (en) * 2016-04-16 2017-10-19 University Of Florida Research Foundation, Incorporated Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
US11326182B2 (en) 2016-04-29 2022-05-10 Voyager Therapeutics, Inc. Compositions for the treatment of disease
US11299751B2 (en) 2016-04-29 2022-04-12 Voyager Therapeutics, Inc. Compositions for the treatment of disease
AU2017267665C1 (en) 2016-05-18 2023-10-05 Voyager Therapeutics, Inc. Modulatory polynucleotides
IL297576B2 (en) 2016-05-18 2024-02-01 Voyager Therapeutics Inc Preparations and methods for treating Huntington's disease
CN110168080B (zh) 2016-08-15 2024-05-31 建新公司 检测aav的方法
US20190185864A1 (en) 2016-08-23 2019-06-20 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
CN110650673B (zh) 2016-08-30 2024-04-09 加利福尼亚大学董事会 用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
EP3619308A4 (en) 2017-05-05 2021-01-27 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS OF TREATMENT FOR HUNTINGTON'S MORBUS
JP2020518258A (ja) 2017-05-05 2020-06-25 ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 筋萎縮性側索硬化症（ａｌｓ）治療組成物および方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
JP2020526203A (ja) * 2017-07-10 2020-08-31 ユニキュアー アイピー ビー．ブイ． ヒトにおけるａａｖ遺伝子療法のための手段及び方法
AU2018302016A1 (en) 2017-07-17 2020-02-06 The Regents Of The University Of California Trajectory array guide system
EP3655538A1 (en) * 2017-07-20 2020-05-27 uniQure IP B.V. Improved aav capsid production in insect cells
MX2020001187A (es) 2017-08-03 2020-10-05 Voyager Therapeutics Inc Composiciones y métodos para la administración de virus adenoasociados.
US20200237799A1 (en) 2017-10-16 2020-07-30 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (als)
TWI804518B (zh) 2017-10-16 2023-06-11 美商航海家醫療公司 肌萎縮性脊髓側索硬化症(als)之治療
CA3084452A1 (en) * 2017-12-29 2019-07-04 Uniqure Ip B.V. Modified viral vectors and methods of making and using the same
GB201800903D0 (en) 2018-01-19 2018-03-07 Oxford Genetics Ltd Vectors
WO2019241486A1 (en) 2018-06-13 2019-12-19 Voyager Therapeutics, Inc. Engineered 5' untranslated regions (5' utr) for aav production
US11702673B2 (en) 2018-10-18 2023-07-18 University Of Florida Research Foundation, Incorporated Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
WO2020104480A1 (en) 2018-11-19 2020-05-28 Uniqure Biopharma B.V. Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
AU2019385638A1 (en) 2018-11-19 2021-06-03 Uniqure Ip B.V. A companion diagnostic to monitor the effects of gene therapy
AU2019382824A1 (en) 2018-11-19 2021-06-03 Uniqure Ip B.V. Method and means to deliver miRNA to target cells
TW202039858A (zh) 2019-01-18 2020-11-01 美商航海家醫療公司 用於生產aav顆粒之方法及系統
EP3924491A4 (en) * 2019-02-15 2022-12-14 Generation Bio Co. MODULATION OF REP PROTEIN ACTIVITY IN CLOSED-END DNA PRODUCTION
CN111084888B (zh) * 2019-03-15 2021-12-28 北京锦篮基因科技有限公司 一种用于治疗严重高甘油三酯血症的基因药物
AU2020263757A1 (en) * 2019-04-24 2021-10-14 Takara Bio Inc. AAV mutant having brain-targeting property
PE20212267A1 (es) * 2019-04-29 2021-11-30 Univ Pennsylvania Nuevas capsides de aav y composiciones que las contienen
AU2020283537A1 (en) * 2019-05-24 2021-12-16 Regeneron Pharmaceuticals, Inc. Modified viral particles and uses thereof
CN114072510A (zh) * 2019-06-27 2022-02-18 X-化学有限公司 用于昆虫细胞和哺乳动物细胞中的蛋白质表达的重组转移载体
US10557149B1 (en) * 2019-07-15 2020-02-11 Vigene Biosciences, Inc. Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
WO2021053018A1 (en) 2019-09-16 2021-03-25 Uniqure Ip B.V. Targeting misspliced transcripts in genetic disorders
IL295747A (en) 2020-02-21 2022-10-01 Akouos Inc Preparations and methods for the treatment of hearing impairment that is not related to age in humans
WO2021195491A2 (en) * 2020-03-26 2021-09-30 Asklepios Biopharmaceutical, Inc. Inducible promoter for viral vector production
AU2021250656A1 (en) 2020-04-02 2022-09-15 Uniqure Biopharma B.V. Dual bifunctional vectors for AAV production
KR20220161297A (ko) 2020-04-02 2022-12-06 유니큐어 바이오파마 비.브이. 신규 세포주
EP4305157A1 (en) 2021-03-09 2024-01-17 Huidagene Therapeutics (Singapore) Pte. Ltd. Engineered crispr/cas13 system and uses thereof
EP4314258A1 (en) 2021-04-02 2024-02-07 uniQure biopharma B.V. Methods for producing single insect cell clones
EP4347798A2 (en) 2021-06-02 2024-04-10 uniQure biopharma B.V. Insect cell production of parvoviral vectors with modified capsid proteins
EP4347849A1 (en) 2021-06-02 2024-04-10 uniQure biopharma B.V. Adeno-associated virus vectors modified to bind high-density lipoprotein
CN117836010A (zh) 2021-06-21 2024-04-05 优尼科生物制药有限公司 改进的裂解程序
WO2023283962A1 (en) 2021-07-16 2023-01-19 Huigene Therapeutics Co., Ltd. Modified aav capsid for gene therapy and methods thereof
WO2023025920A1 (en) 2021-08-26 2023-03-02 Uniqure Biopharma B.V. Insect cell-produced high potency aav vectors with cns-tropism
CN114703203B (zh) * 2022-02-11 2024-08-06 上海渤因生物科技有限公司 杆状病毒载体及其用途
WO2023198702A1 (en) 2022-04-12 2023-10-19 Uniqure Biopharma B.V. Nucleic acid regulation of c9orf72
WO2023198662A1 (en) 2022-04-12 2023-10-19 Uniqure Biopharma B.V. Novel systems for nucleic acid regulation
WO2023198745A1 (en) 2022-04-12 2023-10-19 Uniqure Biopharma B.V. Nucleic acid regulation of apoe
WO2023198663A1 (en) 2022-04-12 2023-10-19 Uniqure Biopharma B.V. Nucleic acid regulation of snca
WO2024078584A1 (zh) * 2022-10-13 2024-04-18 康霖生物科技（杭州）有限公司 腺相关病毒的衣壳蛋白编码基因改造方法
WO2024196965A1 (en) * 2023-03-23 2024-09-26 Carbon Biosciences, Inc. Parvovirus compositions and related methods for gene therapy
WO2024197242A1 (en) * 2023-03-23 2024-09-26 Carbon Biosciences, Inc. Protoparvovirus compositions comprising a protoparvovirus variant vp1 capsid polypeptide and related methods
WO2024218192A1 (en) 2023-04-18 2024-10-24 Uniqure Biopharma B.V. Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs
WO2024218204A1 (en) 2023-04-18 2024-10-24 Uniqure Biopharma B.V. Gene delivery vehicles comprising rna and antibodies

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
DE60039880D1 (en) 1999-06-24 2008-09-25 Amsterdam Molecular Therapeutics Bv Therapie mit lipoproteinlipase (lpl) variant
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
CA2467959C (en) 2001-11-09 2009-03-10 Robert M. Kotin Production of adeno-associated virus in insect cells
US7198951B2 (en) 2001-12-17 2007-04-03 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor
AU2003212708A1 (en) 2002-03-05 2003-09-16 Stichting Voor De Technische Wetenschappen Baculovirus expression system
HUE033158T2 (en) 2003-09-30 2017-11-28 Univ Pennsylvania Adeno-associated virus (AAV) clusters, sequences, vectors containing them, and their use
US8030065B2 (en) 2004-09-22 2011-10-04 St. Jude Children's Research Hospital Expression of factor IX in gene therapy vectors
ES2410133T3 (es) * 2005-10-20 2013-07-01 Uniqure Ip B.V. Vectores de VAA mejorados producidos en células de insecto.
EP3705577A1 (en) * 2006-06-21 2020-09-09 uniQure IP B.V. Aav vectors with improved rep coding sequences for production in insect cells
US8697417B2 (en) * 2007-07-26 2014-04-15 Uniqure Ip B.V. Baculoviral vectors comprising repeated coding sequences with differential codon biases
WO2009154452A1 (en) 2008-06-17 2009-12-23 Amsterdam Molecular Therapeutics B.V. Parvoviral capsid with incorporated Gly-Ala repeat region
WO2011122950A1 (en) 2010-04-01 2011-10-06 Amsterdam Molecular Therapeutics (Amt) Ip B.V. Monomeric duplex aav vectors

Also Published As

Publication number Publication date
IL247729A0 (en) 2016-11-30
US20210222198A1 (en) 2021-07-22
US20170356008A1 (en) 2017-12-14
CA2942289C (en) 2024-05-21
CN106459984B (zh) 2021-09-07
US10837027B2 (en) 2020-11-17
KR102572449B1 (ko) 2023-08-31
AU2015230094B2 (en) 2021-05-27
IL247729B2 (en) 2023-09-01
DK3117005T3 (da) 2024-08-12
CA2942289A1 (en) 2015-09-17
JP2017510264A (ja) 2017-04-13
ZA201606552B (en) 2017-11-29
AU2015230094A1 (en) 2016-09-15
EP3117005B1 (en) 2024-07-03
EP3117005A1 (en) 2017-01-18
PT3117005T (pt) 2024-07-30
AU2015230094A9 (en) 2016-09-22
CN106459984A (zh) 2017-02-22
KR20160131032A (ko) 2016-11-15
MX2016011585A (es) 2016-11-29
EA201691809A1 (ru) 2017-01-30
IL247729B1 (en) 2023-05-01
BR112016020783A2 (pt) 2017-10-03
WO2015137802A1 (en) 2015-09-17
JP6683397B2 (ja) 2020-04-22
JP2020062045A (ja) 2020-04-23
EP4450630A2 (en) 2024-10-23
FI3117005T3 (fi) 2024-08-29

Similar Documents

Publication Publication Date Title
UA120923C2 (uk) Молекула нуклеїнової кислоти, яка кодує капсидний протеїн aav5
CO2017011957A2 (es) Variantes de alfa-amilasa y polinucleótidos que codifican las mismas
ZA202000273B (en) Improved aav capsid production in insect cells
HK1247233A1 (zh) 高效小體積核酸合成
DK3529357T3 (da) Fremgangsmåder til stregkodning af nukleinsyremolekyler fra individuelle celler
EP3741849A3 (en) Protease variants and polynucleotides encoding same
EP3445381A4 (en) AAV PREPARATION IN INSECT CELLS, METHOD AND COMPOSITIONS THEREFOR
MX2019005158A (es) Variantes de glucoamilasa y polinucleotidos que las codifican.
BR112018070506A2 (pt) produção isenta de células de ácido ribonucleico
WO2016066756A3 (en) Protease variants and polynucleotides encoding same
WO2016066757A3 (en) Protease variants and polynucleotides encoding same
MX2018007237A (es) Proteinas de cápside modificadas para un suministro mejorado de vectores de parvovirus.
EP3741848A3 (en) Protease variants and polynucleotides encoding same
AR103225A1 (es) Composiciones detergentes, variantes de lipasa y polinucleótidos que las codifican
WO2016062875A3 (en) Glucoamylase variants and polynucleotides encoding same
EA201592045A1 (ru) Электрохимическое фильтровальное устройство
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
BR112017027527A2 (pt) ?método para a produção de feromônios de mariposas em levedura
DK3242903T3 (da) Sammensætninger til at indføre nukleinsyre i celler
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
WO2014195356A3 (en) Alpha-amylase variants and polynucleotides encoding same
EA201990758A1 (ru) Способ получения электрокомпетентных дрожжевых клеток и способ применения указанных клеток
BR112016009753A2 (pt) método de cultura de células.
BR112017004495A2 (pt) variantes de celobiohidrolase e polinucleotídeos codificando as mesmas
WO2014177541A3 (en) Glucoamylase variants and polynucleotides encoding same